scholarly journals Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain

2021 ◽  
Author(s):  
Andreas A. Kammerlander ◽  
Thomas Mayrhofer ◽  
Maros Ferencik ◽  
Neha J. Pagidipati ◽  
Julia Karady ◽  
...  

<u>Objectives.</u> Determine the association of distinct metabolic phenotypes with coronary artery disease (CAD) and major adverse cardiovascular events (MACE). <p><u>Background</u>. Obesity and metabolic syndrome are associated with MACE. However, whether distinct metabolic phenotypes differ in risk for CAD and MACE is unknown. </p> <p><u>Methods.</u> We included patients from the <i>Prospective Multicenter Imaging Study for Evaluation of Chest Pain·(PROMISE) </i>who underwent coronary computed tomography (CT) angiography. Obesity was defined as a BMI≥30kg/m<sup>2</sup>, and metabolically healthy as ≤1 metabolic syndrome component except diabetes, distinguishing four metabolic phenotypes: metabolically healthy/unhealthy and non-obese/obese (MHN·<br> MHO·MUN·MUO). Differences in severe calcification (CAC≥400), severe CAD (≥70% stenosis), high-risk plaque (HRP), and MACE were assessed using adjusted logistic and Cox-regression models.</p> <p><u>Results.</u> Of 4,381 patients (48.4% male, 60.5±8.1y/o), 49.4% were metabolically healthy (30.7% MHN; 18.7% MHO) and 50.6% unhealthy (22.3% MUN; 28.4% MUO). MHO had similar coronary-CT findings as compared to MHN (severe CAC/CAD and HRP, p>0.36 for all). Among metabolically unhealthy patients, those with obesity had similar CT findings as compared to non-obese (p>0.10 for all). However, both MUN and MUO had unfavorable CAD characteristics as compared to MHN (p≤0.017 for all).</p> <p>130 events occurred during follow-up (median 26 months). Compared to MHN, MUN (HR 1.61·[1.02–2.53]) but not MHO (HR 1.06·[0.62–1.82) or MUO (HR 1.06·[0.66–1.72]) had higher risk for MACE. </p> <p><u>Conclusion.</u> In stable chest pain patients, four metabolic phenotypes exhibit distinctly different CAD characteristics and risk for MACE. Individuals who are metabolically unhealthy despite not being obese were at highest risk in our cohort.<b></b></p>

2021 ◽  
Author(s):  
Andreas A. Kammerlander ◽  
Thomas Mayrhofer ◽  
Maros Ferencik ◽  
Neha J. Pagidipati ◽  
Julia Karady ◽  
...  

<u>Objectives.</u> Determine the association of distinct metabolic phenotypes with coronary artery disease (CAD) and major adverse cardiovascular events (MACE). <p><u>Background</u>. Obesity and metabolic syndrome are associated with MACE. However, whether distinct metabolic phenotypes differ in risk for CAD and MACE is unknown. </p> <p><u>Methods.</u> We included patients from the <i>Prospective Multicenter Imaging Study for Evaluation of Chest Pain·(PROMISE) </i>who underwent coronary computed tomography (CT) angiography. Obesity was defined as a BMI≥30kg/m<sup>2</sup>, and metabolically healthy as ≤1 metabolic syndrome component except diabetes, distinguishing four metabolic phenotypes: metabolically healthy/unhealthy and non-obese/obese (MHN·<br> MHO·MUN·MUO). Differences in severe calcification (CAC≥400), severe CAD (≥70% stenosis), high-risk plaque (HRP), and MACE were assessed using adjusted logistic and Cox-regression models.</p> <p><u>Results.</u> Of 4,381 patients (48.4% male, 60.5±8.1y/o), 49.4% were metabolically healthy (30.7% MHN; 18.7% MHO) and 50.6% unhealthy (22.3% MUN; 28.4% MUO). MHO had similar coronary-CT findings as compared to MHN (severe CAC/CAD and HRP, p>0.36 for all). Among metabolically unhealthy patients, those with obesity had similar CT findings as compared to non-obese (p>0.10 for all). However, both MUN and MUO had unfavorable CAD characteristics as compared to MHN (p≤0.017 for all).</p> <p>130 events occurred during follow-up (median 26 months). Compared to MHN, MUN (HR 1.61·[1.02–2.53]) but not MHO (HR 1.06·[0.62–1.82) or MUO (HR 1.06·[0.66–1.72]) had higher risk for MACE. </p> <p><u>Conclusion.</u> In stable chest pain patients, four metabolic phenotypes exhibit distinctly different CAD characteristics and risk for MACE. Individuals who are metabolically unhealthy despite not being obese were at highest risk in our cohort.<b></b></p>


Diabetes Care ◽  
2021 ◽  
pp. dc201760
Author(s):  
Andreas A. Kammerlander ◽  
Thomas Mayrhofer ◽  
Maros Ferencik ◽  
Neha J. Pagidipati ◽  
Julia Karady ◽  
...  

2007 ◽  
Vol 92 (7) ◽  
pp. 2532-2537 ◽  
Author(s):  
Dao-Fu Dai ◽  
Jou-Wei Lin ◽  
Jia-Horng Kao ◽  
Chih-Neng Hsu ◽  
Fu-Tien Chiang ◽  
...  

Abstract Background: The clinical predictors of inflammation in atherosclerosis remain controversial. The objective of this study was to compare the associations of metabolic factors vs. infectious burden (IB) with inflammation, the severity of coronary atherosclerosis, and major adverse cardiovascular events (MACEs). Design, Setting, and Patients: Coronary angiography with Gensini score was applied to assess the severity of coronary atherosclerosis in 568 patients with coronary artery disease. Metabolic syndrome (MS) score (0–5) was defined according to the modified criteria of National Cholesterol Education Program Adult Treatment Panel III. IB score (0–7) was defined as the number of seropositivities to several agents. Results: IB score was not associated with plasma C-reactive protein (CRP) concentration, Gensini score, or the risk of MACE. In contrast, MS score significantly correlated with both plasma CRP concentration and Gensini score (P &lt; 0.001 for both). MS score and plasma CRP concentration were also significantly associated with the risk of MACE (hazard ratios 1.51, P &lt; 0.001; and 1.90, P = 0.002, respectively). Conclusion: Compared with IB, metabolic abnormalities have a more prominent association with the degree of inflammation, the severity of coronary atherosclerosis, and the risk of MACE in patients with coronary artery disease.


2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Nina Rieckmann ◽  
Konrad Neumann ◽  
Sarah Feger ◽  
Paolo Ibes ◽  
Adriane Napp ◽  
...  

QJM ◽  
2012 ◽  
Vol 105 (12) ◽  
pp. 1231-1231 ◽  
Author(s):  
A. G. Dastidar ◽  
F. Pugliese ◽  
C. Davies ◽  
M. Westwood ◽  
A. Timmis ◽  
...  

2020 ◽  
Vol 93 (1113) ◽  
pp. 20190881 ◽  
Author(s):  
Marly van Assen ◽  
Dirk Jan Kuijpers ◽  
Juerg Schwitter

Perfusion-cardiovascular MR (CMR) imaging has been shown to reliably identify patients with suspected or known coronary artery disease (CAD), who are at risk for future cardiac events and thus, allows for guiding therapy including revascularizations. Accordingly, it is an ideal test to exclude prognostically relevant coronary artery disease. Several guidelines, such as the ESC guidelines, currently recommend CMR as non-invasive testing in patients with stable chest pain. CMR has as an advantage over the more conventional pathways as it lacks radiation and it potentially reduces costs.


2018 ◽  
Vol 83 ◽  
pp. 151-159 ◽  
Author(s):  
Ahmed Abdel Khalek Abdel Razek ◽  
Mohamed Magdy Elrakhawy ◽  
Mahmoud Mohamed Yossof ◽  
Hadeer Mohamed Nageb

Sign in / Sign up

Export Citation Format

Share Document